Abstract
A new antifungal peptide designated as pomegranin, with an N-terminal sequence resembling that of rice disease resistance NB-S-LRR-like protein, was isolated from fresh pomegranate peels by ion exchange chromatography on DEAE-cellulose, affinity chromatography on Affi-gel blue gel, and gel filtration by fast protein liquid chromatography on Superdex 75. Pomegranin was unadsorbed on DEAE-cellulose but adsorbed on Affi-gel blue gel. It exhibited a molecular mass of 11 kDa in both gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It inhibited mycelial growth in the fungi Botrytis cinerea and Fusarium oxysporum with an IC50 of 2 μM and 6.1 μM, respectively. It was devoid of hemagglutinating, ribonuclease, deoxyribonuclease and protease inhibitory activities.
Keywords: antifungal peptide, pomegranate, isolation, peel
Protein & Peptide Letters
Title: Pomegranin, An Antifungal Peptide from Pomegranate Peels
Volume: 16 Issue: 1
Author(s): Guang Guo, He Xiang Wang and Tzi Bun Ng
Affiliation:
Keywords: antifungal peptide, pomegranate, isolation, peel
Abstract: A new antifungal peptide designated as pomegranin, with an N-terminal sequence resembling that of rice disease resistance NB-S-LRR-like protein, was isolated from fresh pomegranate peels by ion exchange chromatography on DEAE-cellulose, affinity chromatography on Affi-gel blue gel, and gel filtration by fast protein liquid chromatography on Superdex 75. Pomegranin was unadsorbed on DEAE-cellulose but adsorbed on Affi-gel blue gel. It exhibited a molecular mass of 11 kDa in both gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It inhibited mycelial growth in the fungi Botrytis cinerea and Fusarium oxysporum with an IC50 of 2 μM and 6.1 μM, respectively. It was devoid of hemagglutinating, ribonuclease, deoxyribonuclease and protease inhibitory activities.
Export Options
About this article
Cite this article as:
Guo Guang, Wang Xiang He and Ng Bun Tzi, Pomegranin, An Antifungal Peptide from Pomegranate Peels, Protein & Peptide Letters 2009; 16(1) . https://dx.doi.org/10.2174/092986609787049330
DOI https://dx.doi.org/10.2174/092986609787049330 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
eBook Review (Review of The Bentham e-Book entitled “Anti-angiogenesis drug discovery and development- Volume 2” edited by Atta-ur-Rahman and M Iqbal Choudhary)
Current Vascular Pharmacology Inflammation, Sleep, Obesity and Cardiovascular Disease.
Current Vascular Pharmacology Wound Repair - Updates in Dressing Patents and Regeneration Biomarkers
Recent Patents on Biomarkers Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility
Current Pharmaceutical Design Decreased Serum Adiponectin Level Affected Clinical Pathological Characteristics of Patients with Gastric Cancer
Current Proteomics The Effects of Physical and Psychological Stress on the Gastrointestinal Tract: Lessons from Animal Models
Current Molecular Medicine Emerging Cytokines in Allergic Airway Inflammation: A Genetic Update
Current Immunology Reviews (Discontinued) Growing Collateral Arteries On Demand
Recent Patents on Cardiovascular Drug Discovery Etiologic Aspects of Pagets Disease of Bone
Current Rheumatology Reviews Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
Current Pharmaceutical Design Atrial Fibrillation Following Cardiac Surgery: Established and Emerging Strategies of Prevention
Recent Patents on Cardiovascular Drug Discovery DNA and RNA Code-reading Molecules as Potential Gene Silencers in Neurobiology- What are They and what are They Good for?
Current Medicinal Chemistry - Central Nervous System Agents Requirements and Perspectives for Integrating Metabolomics with other Omics Data
Current Metabolomics The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets The Clinical and Biological Relationship between Type II Diabetes Mellitus and Alzheimers Disease
Current Alzheimer Research The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique
Current Stem Cell Research & Therapy Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets A Review of Clinical Studies Assessing the Therapeutic Efficacy of Escitalopram: A Step Towards Development
CNS & Neurological Disorders - Drug Targets Protective Effect of Schizolobium parahyba Flavonoids Against Snake Venoms and Isolated Toxins
Current Topics in Medicinal Chemistry